Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …

Direct oral anticoagulants (DOACs) have largely replaced vitamin K antagonists, mostly
warfarin, for the main indications for oral anticoagulation, prevention and treatment of …

Venous thromboembolism (VTE) and thrombocytopenia are frequently encountered
complications in patients with cancer. Although there are several studies evaluating the …

Patients with severe infections and a pre-existing indication for antithrombotic therapy, ie
antiplatelet agents, anticoagulant drugs, or their combinations, require integrated clinical …

Ischemic stroke is an important cause of morbidity and mortality in cancer patients. The
underlying mechanisms linking cancer and stroke are not completely understood. Long …

The antiphospholipid syndrome (APS) is an autoimmune and prothrombotic condition
defined by the association of thrombotic events and/or obstetrical complications and the …

Simple Summary The reported incidence of thrombotic events (TE) in non-promyelocytic
acute myeloid leukemia (AML) patients varies in the literature from 2% to 13%. The aim of …

Background Thrombocytopenia poses a risk of bleeding in patients with chronic coronary
syndrome after coronary intervention. However, whether thrombocytopenia also increases …

Simple Summary Historically, patients with pancreatic ductal adenoma carcinoma were
subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and …

Immune thrombocytopenia (ITP) is a rare and orphan disease. The following
recommendations are meant to assist physicians, dentists, and other health-care …